52-Week Performance Chart

Powered by FactSet Research Systems Inc

Corporate Actions/Books Closed

More
Jan 20, 2026
CSL Limited - Books Closed Announcement
Jan 14, 2026
CSL Limited - Books Closed / Open Announcement
Dec 04, 2025
CSL Limited - Books Closed Announcement

No DR Events are available.

Data provided by Thomson Reuters

Recent Dividends & Distributions

More
US RECORD DATE US PAYABLE DATE NET DR AMOUNT
Sep 10, 2025 Oct 10, 2025 0.7600
Mar 11, 2025 Apr 16, 2025 0.6000
Sep 10, 2024 Oct 09, 2024 0.6750
Mar 12, 2024 Apr 10, 2024 0.5450

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
Domini Impact Investments LLC 69,200
Causeway Capital Management LLC 65,240
Yousif Capital Management LLC 28,986
TOP MUTUAL FUND HOLDERS POSITION
Domini Impact Equity Fund 69,200
ActivePassive International Equity ETF 65,240
Praxis International Index Fund 14,564

Data provided by FactSet Research Systems Inc.

DR Details

DR Symbol CSLLY
CUSIP 12637N204
DR Venue OTC
DR ISIN US12637N2045
Ratio DR:ORD 2:1
Underlying ISIN AU000000CSL8
Country Australia
Effective Date Jan 27, 2026
Depositary DB (Sponsored)
Industry Pharma. & Biotech.
CSL is engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical products and vaccines. The Company's operating segments are: CSL Behring and CSL Seqirus. The Company's CSL Behring segment manufactures, markets, and distributes plasma therapies (plasma products and recombinants), conducts early-stage research on plasma and non-plasma therapies, excluding influenza, and focuses on the commercialization of intellectual property. The Company's CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products and develops influenza related products.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Mar.26 24.55 13,255,921 602,542
Feb.26 52.11 3,550,436 186,865
Jan.26 62.95 2,377,977 118,899

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE